Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Earnings for Revenio Group Oyj (REG1V.HE)
Earnings in 2023 (TTM): $27.48 M
According to Revenio Group Oyj's latest financial reports the company's current earnings (TTM) are $27.48 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Revenio Group Oyj
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $27.48 M | $20.68 M |
| 2022 | $31.44 M | $23.54 M |
| 2021 | $23.91 M | $18.74 M |
| 2020 | $18.09 M | $14.46 M |
| 2019 | $13.28 M | $10.11 M |
| 2018 | $11.07 M | $8.77 M |
| 2017 | $8.97 M | $7.41 M |
| 2016 | $7.7 M | $6.04 M |
| 2015 | $6.39 M | $7.03 M |
| 2014 | $5.04 M | $-750,904 |
| 2013 | $5.94 M | $4.69 M |
| 2012 | $5.07 M | $-310,532 |
| 2011 | $3.32 M | $4.23 M |
| 2010 | $-710,870 | $-548,571 |
| 2009 | $-905,629 | $-881,825 |
| 2008 | $3.93 M | $2.88 M |
| 2005 | $882.91 K | $2.46 M |
| 2004 | $-1,100,089 | $-1,101,471 |
| 2003 | $-3,016,147 | $-3,481,966 |
| 2002 | $-7,969,489 | $-8,339,448 |